“…It accounts for ~90% of cases of rhino-orbital-cerebral mucormycosis (ROCM), especially in those with poorly controlled diabetes mellitus and ketoacidosis [ 5 , 9 , 10 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ], but also in ostensibly immunocompetent individuals [ 24 , 25 , 26 ]. In addition, it is the leading cause (~70% of all cases) of pulmonary, gastrointestinal, cutaneous, and sub-cutaneous disseminated mucormycosis in immunocompromised individuals with haematological malignancies, solid organ and stem cell transplant recipients, and those receiving high-dose intravenous corticosteroids [ 7 , 9 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 ]. The fungus has emerged as the cause of necrotising super-infections in patients with severe influenza and with SARS-CoV-2 [ 46 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 ,…”